NCT01411267 2022-04-04AC220 for Children With Relapsed/Refractory ALL or AMLTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Completed24 enrolled 14 charts
NCT01861002 2021-06-09A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AMLTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Completed15 enrolled 10 charts